
Inflammatory bowel disease in the U.S. - Statistics & Facts
Key insights
- Number of adults aged 18 to 24 years with Crohn's disease or ulcerative colitis in the U.S.
- 152,000

Detailed statistics
Prevalence of inflammatory bowel disease in the U.S. in 2015-2016, by age
- U.S. region with the highest percentage of people with Crohn's disease or ulcerative colitis
- Northeast/South

Detailed statistics
Incidence of inflammatory bowel disease in the U.S. in 2015-2016, by region
- Most common symptom among IBD patients in the U.S.
- Fatigue

Detailed statistics
IBD patients that experienced select IBD symptoms in the U.S. as of 2019
Editor’s Picks Current statistics on this topic
Current statistics on this topic
Related topics
Recommended statistics
Global overview
5
- Basic Statistic Projected IBD population in select countries in NA and Europe in 2010, 2020, and 2030
- Basic Statistic Most common Crohn's disease symptoms among Crohn's patients worldwide as of 2019
- Basic Statistic Most common symptoms among ulcerative colitis patients worldwide in 2019
- Basic Statistic Severity of common symptoms of inflammatory bowel disease worldwide 2019
- Basic Statistic IBD patients worldwide discontinuing medication due to side effect concerns 2019
Global overview
-
Basic Statistic
Projected IBD population in select countries in NA and Europe in 2010, 2020, and 2030
Projected IBD population in select countries in NA and Europe in 2010, 2020, and 2030
Projected prevalence of inflammatory bowel disease (IBD) in select countries in North America and Europe in 2010, 2020, and 2030
-
Basic Statistic
Most common Crohn's disease symptoms among Crohn's patients worldwide as of 2019
Most common Crohn's disease symptoms among Crohn's patients worldwide as of 2019
Percentage of Crohn's disease patients worldwide who reported select symptoms as of 2019*
-
Basic Statistic
Most common symptoms among ulcerative colitis patients worldwide in 2019
Most common symptoms among ulcerative colitis patients worldwide in 2019
Percentage of ulcerative colitis (UC) patients worldwide who reported select symptoms as of 2019
-
Basic Statistic
Severity of common symptoms of inflammatory bowel disease worldwide 2019
Severity of common symptoms of inflammatory bowel disease worldwide 2019
Percentage of patients with inflammatory bowel disease worldwide who reported symptoms were severe as of 2019
-
Basic Statistic
IBD patients worldwide discontinuing medication due to side effect concerns 2019
IBD patients worldwide discontinuing medication due to side effect concerns 2019
Percentage of IBD patients worldwide reporting discontinuing medication due to concerns about side effects as of 2019*
U.S. prevalence
4
- Basic Statistic Prevalence of inflammatory bowel disease in the U.S. in 2015-2016, by gender
- Premium Statistic Prevalence of inflammatory bowel disease in the U.S. in 2015-2016, by age
- Premium Statistic Incidence of inflammatory bowel disease in the U.S. in 2015-2016, by ethnicity
- Basic Statistic Incidence of inflammatory bowel disease in the U.S. in 2015-2016, by region
U.S. prevalence
-
Basic Statistic
Prevalence of inflammatory bowel disease in the U.S. in 2015-2016, by gender
Prevalence of inflammatory bowel disease in the U.S. in 2015-2016, by gender
Number of adults with Crohn's disease or ulcerative colitis in the U.S. in 2015-2016, by gender
-
Premium Statistic
Prevalence of inflammatory bowel disease in the U.S. in 2015-2016, by age
Prevalence of inflammatory bowel disease in the U.S. in 2015-2016, by age
Number of adults with Crohn's disease or ulcerative colitis in the U.S. in 2015-2016, by age
-
Premium Statistic
Incidence of inflammatory bowel disease in the U.S. in 2015-2016, by ethnicity
Incidence of inflammatory bowel disease in the U.S. in 2015-2016, by ethnicity
Percentage of adults with Crohn's disease or ulcerative colitis in the U.S. in 2015-2016, by ethnicity
-
Basic Statistic
Incidence of inflammatory bowel disease in the U.S. in 2015-2016, by region
Incidence of inflammatory bowel disease in the U.S. in 2015-2016, by region
Percentage of adults with Crohn's disease or ulcerative colitis in the U.S. in 2015-2016, by region
Symptoms and treatment
7
- Basic Statistic Quality of life measures among IBD patients in the U.S. as of 2018
- Premium Statistic IBD patients that experienced select IBD symptoms in the U.S. as of 2019
- Basic Statistic Severity and frequency of Crohn's disease symptoms among U.S. sufferers as of 2019
- Basic Statistic Strategies used to improve IBD symptoms among U.S. respondents with IBD as of 2020
- Premium Statistic Strategies to cope with Crohn's flares reported by Crohn's patients in the U.S. 2019
- Basic Statistic Treatments used by IBD patients in the U.S. as of 2018
- Basic Statistic Health care utilization among U.S. adults with IBD in 2015 and 2016
Symptoms and treatment
-
Basic Statistic
Quality of life measures among IBD patients in the U.S. as of 2018
Quality of life measures among IBD patients in the U.S. as of 2018
Percentage of U.S. adults with inflammatory bowel disease (IBD) who stated their IBD impacted their life in select ways as of 2018
-
Premium Statistic
IBD patients that experienced select IBD symptoms in the U.S. as of 2019
IBD patients that experienced select IBD symptoms in the U.S. as of 2019
Percentage of U.S. inflammatory bowel disease (IBD) patients that experienced select symptoms associated with IBD as of 2019
-
Basic Statistic
Severity and frequency of Crohn's disease symptoms among U.S. sufferers as of 2019
Severity and frequency of Crohn's disease symptoms among U.S. sufferers as of 2019
Severity and frequency of Crohn's disease symptoms reported by Crohn's patients in the U.S. as of 2019
-
Basic Statistic
Strategies used to improve IBD symptoms among U.S. respondents with IBD as of 2020
Strategies used to improve IBD symptoms among U.S. respondents with IBD as of 2020
Percentage of people with inflammatory bowel disease (IBD) in the United States who used select strategies to improve IBD symptoms as of 2020
-
Premium Statistic
Strategies to cope with Crohn's flares reported by Crohn's patients in the U.S. 2019
Strategies to cope with Crohn's flares reported by Crohn's patients in the U.S. 2019
Percentage of Crohn's patients in the United States who used select strategies to cope with flares as of 2019
-
Basic Statistic
Treatments used by IBD patients in the U.S. as of 2018
Treatments used by IBD patients in the U.S. as of 2018
Percentage of U.S. adults with inflammatory bowel disease (IBD) who used select treatments to manage their IBD as of 2018
-
Basic Statistic
Health care utilization among U.S. adults with IBD in 2015 and 2016
Health care utilization among U.S. adults with IBD in 2015 and 2016
Percentage of U.S. adults with inflammatory bowel disease (IBD) who utilized select health care resources in the past 12 months as of 2015-2016
Prevalence among older adults
5
- Basic Statistic Number of Medicare fee-for-service beneficiaries with inflammatory bowel disease 2018
- Basic Statistic Share of Medicare fee-for-service beneficiaries with inflammatory bowel disease 2018
- Premium Statistic Share of Medicare beneficiaries with inflammatory bowel disease in 2018, by gender
- Basic Statistic Share of Medicare beneficiaries with inflammatory bowel disease in 2018, by age
- Basic Statistic Share of Medicare beneficiaries with inflammatory bowel disease in 2018, by ethnicity
Prevalence among older adults
-
Basic Statistic
Number of Medicare fee-for-service beneficiaries with inflammatory bowel disease 2018
Number of Medicare fee-for-service beneficiaries with inflammatory bowel disease 2018
Number of Medicare fee-for-service beneficiaries in the United States with Crohn's disease and ulcerative colitis in 2018
-
Basic Statistic
Share of Medicare fee-for-service beneficiaries with inflammatory bowel disease 2018
Share of Medicare fee-for-service beneficiaries with inflammatory bowel disease 2018
Share of Medicare fee-for-service beneficiaries in the United States with Crohn's disease and ulcerative colitis in 2018*
-
Premium Statistic
Share of Medicare beneficiaries with inflammatory bowel disease in 2018, by gender
Share of Medicare beneficiaries with inflammatory bowel disease in 2018, by gender
Share of Medicare fee-for-service beneficiaries in the United States with Crohn's disease and ulcerative colitis in 2018, by gender
-
Basic Statistic
Share of Medicare beneficiaries with inflammatory bowel disease in 2018, by age
Share of Medicare beneficiaries with inflammatory bowel disease in 2018, by age
Share of Medicare fee-for-service beneficiaries in the United States with Crohn's disease and ulcerative colitis in 2018, by age group
-
Basic Statistic
Share of Medicare beneficiaries with inflammatory bowel disease in 2018, by ethnicity
Share of Medicare beneficiaries with inflammatory bowel disease in 2018, by ethnicity
Share of Medicare fee-for-service beneficiaries in the United States with Crohn's disease and ulcerative colitis in 2018, by ethnicity
Hospitalizations among older adults
6
- Basic Statistic Hospitalizations for IBD among older U.S. adults in 2017, by gender
- Basic Statistic Hospitalizations for IBD among older U.S. adults in 2017, by age
- Basic Statistic Hospitalization rate for IBD among older U.S. adults in 2017, by gender
- Basic Statistic Hospitalization rate for IBD among older U.S. adults in 2017, by age
- Basic Statistic Length of hospital stays for IBD among older U.S. adults in 2017, by gender
- Basic Statistic Length of hospital stays for IBD among older U.S. adults in 2017, by age
Hospitalizations among older adults
-
Basic Statistic
Hospitalizations for IBD among older U.S. adults in 2017, by gender
Hospitalizations for IBD among older U.S. adults in 2017, by gender
Number of hospitalizations for Crohn's disease and ulcerative colitis among Medicare fee-for-service beneficiaries in the U.S. in 2017, by gender*
-
Basic Statistic
Hospitalizations for IBD among older U.S. adults in 2017, by age
Hospitalizations for IBD among older U.S. adults in 2017, by age
Number of hospitalizations for Crohn's disease and ulcerative colitis among Medicare fee-for-service beneficiaries in the U.S. in 2017, by age*
-
Basic Statistic
Hospitalization rate for IBD among older U.S. adults in 2017, by gender
Hospitalization rate for IBD among older U.S. adults in 2017, by gender
Rate of hospitalizations for Crohn's disease and ulcerative colitis among Medicare fee-for-service beneficiaries in the U.S. in 2017, by gender (per 100,000 enrollees)*
-
Basic Statistic
Hospitalization rate for IBD among older U.S. adults in 2017, by age
Hospitalization rate for IBD among older U.S. adults in 2017, by age
Rate of hospitalizations for Crohn's disease and ulcerative colitis among Medicare fee-for-service beneficiaries in the U.S. in 2017, by age (per 100,000 enrollees)*
-
Basic Statistic
Length of hospital stays for IBD among older U.S. adults in 2017, by gender
Length of hospital stays for IBD among older U.S. adults in 2017, by gender
Average length of stay in hospital for Crohn's disease and ulcerative colitis among Medicare fee-for-service beneficiaries in the U.S. in 2017, by gender (in days)*
-
Basic Statistic
Length of hospital stays for IBD among older U.S. adults in 2017, by age
Length of hospital stays for IBD among older U.S. adults in 2017, by age
Average length of stay in hospital for Crohn's disease and ulcerative colitis among Medicare fee-for-service beneficiaries in the U.S. in 2017, by age (in days)*
Surgery and death among older adults
4
- Basic Statistic Surgery rate for IBD among older U.S. adults in 2017, by gender
- Basic Statistic Surgery rate for IBD among older U.S. adults in 2017, by age
- Premium Statistic Mortality rate for IBD among older U.S. adults in 2017, by gender
- Premium Statistic Mortality rate for IBD among older U.S. adults in 2017, by age
Surgery and death among older adults
-
Basic Statistic
Surgery rate for IBD among older U.S. adults in 2017, by gender
Surgery rate for IBD among older U.S. adults in 2017, by gender
Rate of surgery for Crohn's disease and ulcerative colitis among Medicare fee-for-service beneficiaries in the U.S. in 2017, by gender (per 100 hospital stays)*
-
Basic Statistic
Surgery rate for IBD among older U.S. adults in 2017, by age
Surgery rate for IBD among older U.S. adults in 2017, by age
Rate of surgery for Crohn's disease and ulcerative colitis among Medicare fee-for-service beneficiaries in the U.S. in 2017, by age (per 100 hospital stays)*
-
Premium Statistic
Mortality rate for IBD among older U.S. adults in 2017, by gender
Mortality rate for IBD among older U.S. adults in 2017, by gender
30-day mortality rate for Crohn's disease and ulcerative colitis among Medicare fee-for-service beneficiaries in the U.S. in 2017, by gender (per 100 hospital stays)*
-
Premium Statistic
Mortality rate for IBD among older U.S. adults in 2017, by age
Mortality rate for IBD among older U.S. adults in 2017, by age
30-day mortality rate for Crohn's disease and ulcerative colitis among Medicare fee-for-service beneficiaries in the U.S. in 2017, by age (per 100 hospital stays)*
Miscellaneous
7
- Basic Statistic Diagnostics used in the diagnosis of IBD patients in the U.S. as of 2018
- Premium Statistic U.S. adults with IBD and select chronic conditions in 2015-2016
- Basic Statistic Smoking prevalence among U.S. adults with IBD from 2015-2016
- Premium Statistic Weight status of U.S. adults with IBD from 2015-2016
- Basic Statistic U.S. adults with IBD under psychological distress from 2015-2016
- Premium Statistic Saving of U.S. costs through generic pharmaceuticals by condition 2022
- Basic Statistic Leading therapy areas by commercial PMPM spending U.S. 2020-2021
Miscellaneous
-
Basic Statistic
Diagnostics used in the diagnosis of IBD patients in the U.S. as of 2018
Diagnostics used in the diagnosis of IBD patients in the U.S. as of 2018
Percentage of U.S. adults with inflammatory bowel disease that had select diagnostics tests for diagnosis as of 2018
-
Premium Statistic
U.S. adults with IBD and select chronic conditions in 2015-2016
U.S. adults with IBD and select chronic conditions in 2015-2016
Percentage of U.S. adults with inflammatory bowel disease and select chronic conditions in 2015-2016
-
Basic Statistic
Smoking prevalence among U.S. adults with IBD from 2015-2016
Smoking prevalence among U.S. adults with IBD from 2015-2016
Percentage of U.S. adults with inflammatory bowel disease who smoked in 2015-2016
-
Premium Statistic
Weight status of U.S. adults with IBD from 2015-2016
Weight status of U.S. adults with IBD from 2015-2016
Percentage of U.S. adults with inflammatory bowel disease who were overweight or obese in 2015 and 2016
-
Basic Statistic
U.S. adults with IBD under psychological distress from 2015-2016
U.S. adults with IBD under psychological distress from 2015-2016
Percentage of U.S. adults with inflammatory bowel disease who were under serious psychological distress from 2015-2016
-
Premium Statistic
Saving of U.S. costs through generic pharmaceuticals by condition 2022
Saving of U.S. costs through generic pharmaceuticals by condition 2022
Cost savings through generics in the United States in 2022, by major condition (in billion U.S. dollars)
-
Basic Statistic
Leading therapy areas by commercial PMPM spending U.S. 2020-2021
Leading therapy areas by commercial PMPM spending U.S. 2020-2021
Leading therapy areas in the U.S. by commercial PMPM spending in 2020-2021 (in U.S. dollars)
Further reportsGet the best reports to understand your industry
Get the best reports to understand your industry
Contact
Get in touch with us. We are happy to help.

Meredith Alda
Sales Manager– Contact (United States)
Mon - Fri, 9am - 6pm (EST)

Yolanda Mega
Operations Manager– Contact (Asia)
Mon - Fri, 9am - 5pm (SGT)

Kisara Mizuno
Senior Business Development Manager– Contact (Asia)
Mon - Fri, 10:00am - 6:00pm (JST)

Lodovica Biagi
Director of Operations– Contact (Europe)
Mon - Fri, 9:30am - 5pm (GMT)

Carolina Dulin
Group Director - LATAM– Contact (Latin America)
Mon - Fri, 9am - 6pm (EST)